BEZ235 + MEK162
CMEK162X2103
Phase 1 small_molecule completed
Quick answer
BEZ235 + MEK162 for Unspecified Adult Solid Tumor, Protocol Specific is a Phase 1 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Unspecified Adult Solid Tumor, Protocol Specific
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed